SEC Form 4 · accession 0001179110-15-006433
PTC THERAPEUTICS, INC. · PTCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Neil Gregory Almstead
Officer — EVP Research Pharma Ops & Tech
Period of report
Apr 15, 2015
Accepted (ET)
Apr 17, 2015 · 6:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070081
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Apr 15, 2015 | S | 5,400 | $68.35 | D | 4,111 | D | |
| Common StockF3 | Apr 15, 2015 | S | 4,111 | $69.04 | D | 0 | D | |
| Common Stock | holding | — | — | — | 1,295 | I | By spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F4 | $51.00 | holding | — | — | — | — | Jan 1, 2025 | Common Stock | 69,550 | 69,550 | D |
| Stock Option (Right to Buy)F5 | $27.05 | holding | — | — | — | — | Jan 27, 2024 | Common Stock | 40,000 | 40,000 | D |
| Stock Option (Right to Buy)F6 | $10.85 | holding | — | — | — | — | May 15, 2023 | Common Stock | 70,312 | 70,312 | D |
| Stock Option (Right to Buy)F7 | $10.85 | holding | — | — | — | — | May 15, 2023 | Common Stock | 9,688 | 9,688 | D |
| Stock Option (Right to Buy)F8 | $218.40 | holding | — | — | — | — | Jan 10, 2022 | Common Stock | 166 | 166 | D |
| Stock Option (Right to Buy)F9 | $490.80 | holding | — | — | — | — | Apr 27, 2021 | Common Stock | 216 | 216 | D |
| Stock Option (Right to Buy)F9 | $1,149.60 | holding | — | — | — | — | Feb 2, 2020 | Common Stock | 200 | 200 | D |
| Stock Option (Right to Buy)F9 | $451.20 | holding | — | — | — | — | May 15, 2019 | Common Stock | 200 | 200 | D |
| Stock Option (Right to Buy)F9 | $735.60 | holding | — | — | — | — | Apr 1, 2018 | Common Stock | 194 | 194 | D |
| Stock Option (Right to Buy)F9 | $735.60 | holding | — | — | — | — | Jan 25, 2018 | Common Stock | 166 | 166 | D |
| Stock Option (Right to Buy)F9 | $626.40 | holding | — | — | — | — | Apr 18, 2017 | Common Stock | 137 | 137 | D |
| Stock Option (Right to Buy)F9 | $392.40 | holding | — | — | — | — | Mar 1, 2016 | Common Stock | 119 | 119 | D |
| Stock Option (Right to Buy)F9 | $226.80 | holding | — | — | — | — | May 24, 2015 | Common Stock | 106 | 106 | D |
| Stock Option (Right to Buy)F4 | $51.00 | holding | — | — | — | — | Jan 1, 2025 | Common Stock | 2,060 | 2,060 | I |
| Stock Option (Right to Buy)F5 | $27.05 | holding | — | — | — | — | Jan 27, 2024 | Common Stock | 1,300 | 1,300 | I |
| Stock Option (Right to Buy)F10 | $10.85 | holding | — | — | — | — | May 15, 2023 | Common Stock | 600 | 600 | I |
| Stock Option (Right to Buy)F8 | $218.40 | holding | — | — | — | — | Jan 10, 2022 | Common Stock | 7 | 7 | I |
| Stock Option (Right to Buy)F9 | $490.80 | holding | — | — | — | — | Apr 27, 2021 | Common Stock | 7 | 7 | I |
| Stock Option (Right to Buy)F9 | $1,149.60 | holding | — | — | — | — | Feb 2, 2020 | Common Stock | 1 | 1 | I |
| Stock Option (Right to Buy)F9 | $508.80 | holding | — | — | — | — | Oct 7, 2019 | Common Stock | 12 | 12 | I |
Explanation of responses
- F1The sale transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan.
- F10This option was granted on May 15, 2013 and vests over two years, with 50% of the shares underlying the option vested on May 15, 2014 and the remaining 50% of the original number of shares underlying the option vesting on May 15, 2015.
- F2This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $67.74 to $68.60 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F3This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $68.79 to $69.65 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F4This option was granted on January 2, 2015, and vests over four years, with 25% of the shares underlying the option vesting on January 1, 2016, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2016.
- F5This option was granted on January 28, 2014, and vests over four years, with 25% of the shares underlying the option vesting on January 1, 2015, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2015.
- F6This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter, beginning on June 15, 2014.
- F7This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on December 31, 2013 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter, beginning on January 31, 2014.
- F8This option was granted on January 10, 2012 and vests over four years, with 25% of the shares underlying the option vested on January 1, 2013 and an additional 6.25% of the original number of shares underlying the option vesting quarterly thereafter beginning on April 1, 2013.
- F9Currently exercisable.